Biomaterials and Medical Devices and Drug Delivery Research and Enterprise Group

Organization profile

Profile Information

The Biomaterials and Medical Devices and Drug Delivery Research and Enterprise Group aims to provide material based solutions to emerging global health and environmental priorities. In broad terms we undertake research into the structure, design and functional performance of natural and synthetically derived pure and composite biomaterials with diagnostic or therapeutic impact on living systems.

Our research is organised into the overlapping research areas of nanostructured biomaterials, smart and bioresponsive biomaterials and the biointerface. Key strengths are in the blend of fundamental and applied research involving international innovation networks with academic, industrial and clinical partners to maximise research training potential and translational impact. This allows a range of diverse and multidisciplinary research interests surrounding the structure, design and functional performance of advanced materials for use in biological and environmental systems. The applications for these materials range from medical device technologies and tissue constructs, nanotechnology, drug delivery systems, cardiovascular stenting, biosensor systems in disease diagnosis, ophthalmic biomaterials, materials which moderate host response biology, environmental decontamination and smart textile design.

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

UCON 50-HB-5100 Medicine & Life Sciences
Cryogels Chemical Compounds
Adsorption Medicine & Life Sciences
Polymers Chemical Compounds
Nanoparticles Chemical Compounds
Scaffolds Chemical Compounds
Bacteriophages Medicine & Life Sciences
Ethylene Oxide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2017 2019

Research Output 2014 2019

Anti‐biofilm potential of purified environmental bacteriophage preparations against early stage Pseudomonas aeruginosa biofilms

Issa, R., Chanishvili, N., Caplin, J., Kakabadze, E., Bakuradze, N., Makalatia, K. & Cooper, I., 2 Mar 2019, In : Journal of Applied Microbiology. 126, 6, p. 1657-1667 11 p.

Research output: Contribution to journalArticleResearchpeer-review

Pseudomonas aeruginosa

Green synthesis of Pluronic stabilized reduced graphene oxide: Chemical and biological characterization

Cherian, R., Sandeman, S., Ray, S., Savina, I., Ashtami, J. & Mohanan, PV., 25 Mar 2019, In : Colloids and Surfaces B: Biointerfaces. 179, 19, p. 94-106 13 p.

Research output: Contribution to journalArticleResearchpeer-review


Offensive waste valorisation in the UK: Assessment of the potentials for absorbent hygiene product (AHP) recycling

Takaya, C., Cooper, I., Berg, M., Brittle, S., Muir, R. & Sarker, D., 20 Mar 2019, In : Waste Management. 88, p. 56-70 15 p.

Research output: Contribution to journalArticleResearchpeer-review

packaging waste

Activities 2010 2019

Journal of Applied Microbiology (Journal)

Rahaf Issa (Reviewer), Nina Chanishvili (Reviewer), Jon Caplin (Reviewer), E Kakabadze (Reviewer), N Bakuradze (Reviewer), K Makalatia (Reviewer), Ian Cooper (Reviewer)
2 Mar 2019

Activity: Publication peer-review and editorial workPublication Peer-review

Frontiers in Microbiology: Antimicrobials, Resistance and Chemotherapy (External organisation)

Ian Cooper (Chair)
17 May 2019

Activity: External boards and professional/academic bodiesMembership of professional body

An Introduction to Bacteriophages

Ian Cooper (Presenter)
25 May 2018

Activity: External talk or presentationInvited talk